Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study
Open accessAbstract
Importance: Nonalcoholic fatty liver disease (NAFLD) is a common condition that is most often asymptomatic. It is associated with metabolic syndrome, incident diabetes, carotid atherosclerosis, and endothelial dysfunction, conditions that in turn are strongly linked with brain damage and cognitive impairment. However, it is not known whether NAFLD is associated with structural brain measures in humans. Objective: To assess the association between prevalent NAFLD and brain magnetic resonance imaging (MRI) measures. Design, Setting, and Participants: The cross-sectional association between NAFLD and brain MRI measures was assessed from November 6, 2002, to March 16, 2011, in 766 individuals from the Offspring cohort of the Framingham Study. Participants were included if they did not have excessive alcohol intake and were free of stroke and dementia. Data analysis was conducted from December 30, 2015, to June 15, 2016. Exposures: Nonalcoholic fatty liver disease was assessed by multidetector computed tomographic scans of the abdomen. Main Outcomes and Measures: Linear or logistic regression models were used to evaluate the cross-sectional association between NAFLD and brain MRI measures, adjusting for age, sex, alcohol consumption, visceral adipose tissue, body mass index, menopausal status, systolic blood pressure, hypertension, current smoking, high-density lipoprotein and low-density lipoprotein cholesterol levels, lipid treatment, type 2 diabetes, cardiovascular disease, physical activity, insulin resistance, C-reactive protein levels, and plasma homocysteine values. Brain MRI measures included total cerebral brain volume, hippocampal and white matter hyperintensity volumes, and presence or absence of covert brain infarcts. Results: Of the 766 individuals in the study sample (410 women and 356 men; mean [SD] age at the time of brain MRI, 67 [9] years), 137 (17.9%) had NAFLD. Nonalcoholic fatty liver disease was significantly associated with smaller total cerebral brain volume even after adjustment for all the covariates included in the study (β [SE], -0.26 [0.11]; P = .02). Differences in total cerebral brain volume between those with and without NAFLD corresponded to 4.2 years of brain aging in the general sample and to 7.3 years in individuals younger than 60 years of age. No statistically significant associations were observed between NAFLD and hippocampal or white matter hyperintensity volumes or covert brain infarcts. Conclusions and Relevance: Nonalcoholic fatty liver disease is associated with a smaller total cerebral brain volume, independent of visceral adipose tissue and cardiometabolic risk factors, pointing to a possible link between hepatic steatosis and brain aging.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Liver biopsies from older adults revealed that the degree of liver ageing is related to the severity of nonalcoholic fatty liver disease (NAFLD), which increases the brain age by approximately 4.2 years.
“Liver biopsies from older adults revealed that the degree of liver ageing is related to the severity of nonalcoholic fatty liver disease (NAFLD),220 which increases the brain age by approximately 4.2 years.221”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [221]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811 · see citing works
Self-citationVernon, G. C., Baranova, A. V., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,067 · see citing works
Fox, C. S., Massaro, J. M., Hoffmann, U., Pou, K. M., Maurovich-Horvat, P., Liu, C.-Y., Vasan, R. S., Murabito, J. M., Meigs, J. B., Cupples, L. A., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.675355 · Cited by 2,882 · see citing works
Self-citationVilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., Friedman, S. L., Diago, M., & Romero-Gomez, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.005 · Cited by 2,492 · see citing works
Williams, C. D., Stengel, J. Z., Asike, M., Torres, D. M., Shaw, J. C., Contreras, M., Landt, C. L., & Harrison, S. A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.09.038 · Cited by 2,146 · see citing works
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Targher, G., Day, C. P., & Bonora, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912063 · Cited by 1,907 · see citing works
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Anstee, Q. M., Targher, G., & Day, C. P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.41 · Cited by 1,747 · see citing works
Loomba, R. S., & Sanyal, A. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.171 · Cited by 1,696 · see citing works
The framingham offspring study. Design and preliminary data
Feinleib, M., Kannel, W. B., Garrison, R. J., McNamara, P. M., & Castelli, W. P. (1975) · Preventive Medicine · doi:10.1016/0091-7435(75)90037-7 · Cited by 931 · see citing works
Pou, K. M., Massaro, J. M., Hoffmann, U., Vasan, R. S., Maurovich‐Horvat, P., Larson, M. G., Keaney, J. F., Meigs, J. B., Lipinska, I., Kathiresan, S., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.710509 · Cited by 898 · see citing works
Self-citationMitchell, G. F., van Buchem, M. A., Sigurdsson, S. O., Gotal, J. D., Jónsdóttir, M. K., Kjartansson, Ó., García, M., Aspelund, T., Harris, T. B., Gudnason, V. G., et al. (2011) · Brain · doi:10.1093/brain/awr253 · Cited by 891 · see citing works
Some health benefits of physical activity. The Framingham Study
Kannel, W. B. (1979) · Archives of Internal Medicine · doi:10.1001/archinte.139.8.857 · Cited by 783 · see citing works
Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline
Debette, S., Seshadri, S., Beiser, A., Au, R., Himali, J. J., Palumbo, C., Wolf, P. A., & DeCarli, C. (2011) · Neurology · doi:10.1212/wnl.0b013e318227b227 · Cited by 772 · see citing works
Self-citationNonalcoholic fatty liver disease: A precursor of the metabolic syndrome
Lonardo, A., Ballestri, S., Marchesini, G., Angulo, P., & Loria, P. (2014) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.09.020 · Cited by 685 · see citing works
DeCarli, C., Massaro, J., Harvey, D., Hald, J., Tullberg, M., Au, R., Beiser, A., D’Agostino, R., & Wolf, P. A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.05.004 · Cited by 680 · see citing works
Self-citationFrancque, S., van der Graaff, D., & Kwanten, W. J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.005 · Cited by 557 · see citing works
Causes and Metabolic Consequences of Fatty Liver
Stefan, N., Kantartzis, K., & Häring, H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0009 · Cited by 529 · see citing works
Debette, S., Beiser, A., DeCarli, C., Au, R., Himali, J. J., Kelly-Hayes, M., Romero, J. R., Kase, C. S., Wolf, P. A., & Seshadri, S. (2010) · Stroke · doi:10.1161/strokeaha.109.570044 · Cited by 508 · see citing works
Self-citationThe role of hepatokines in metabolism
Stefan, N., & Häring, H.-U. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.258 · Cited by 500 · see citing works
Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI
Jack, C. R., Shiung, M. M., Weigand, S. D., O’Brien, P. C., Gunter, J. L., Boeve, B. F., Knopman, D. S., Smith, G. E., Ivnik, R. J., Tangalos, E. G., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000180958.22678.91 · Cited by 492 · see citing works
Stroke Risk Profile Predicts White Matter Hyperintensity Volume: The Framingham Study
Jeerakathil, T., Wolf, P. A., Beiser, A., Massaro, J., Seshadri, S., D’Agostino, R. B., & DeCarli, C. (2004) · Stroke · doi:10.1161/01.str.0000135226.53499.85 · Cited by 479 · see citing works
Self-citationSpeliotes, E. K., Massaro, J. M., Hoffmann, U., Vasan, R. S., Meigs, J. B., Sahani, D. V., Hirschhorn, J. N., O’Donnell, C. J., & Fox, C. S. (2010) · Hepatology · doi:10.1002/hep.23593 · Cited by 431 · see citing works
Self-citationSookoian, S. C., & Pirola, C. J. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.06.012 · Cited by 402 · see citing works
Molecular pathways in non-alcoholic fatty liver disease
Auguet, T., Berlanga, A., Guiu‐Jurado, E., & Porras, J. A. (2014) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s62831 · Cited by 380 · see citing works
Kim, D.-G., Krenz, A., Toussaint, L. E., Maurer, K. J., Robinson, S.-A., Yan, A., Torres, L., & Bynoe, M. S. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0467-5 · Cited by 330 · see citing works
Prevalence and Correlates of Silent Cerebral Infarcts in the Framingham Offspring Study
Das, R. R., Seshadri, S., Beiser, A. S., Kelly-Hayes, M., Au, R., Himali, J. J., Kase, C. S., Benjamin, E. J., Polak, J. F., O'Donnell, C. J., et al. (2008) · Stroke · doi:10.1161/strokeaha.108.516575 · Cited by 324 · see citing works
Self-citationWu, S., Wu, F., Ding, Y., Hou, J., Bi, J., & Zhang, Z. (2016) · Scientific Reports · doi:10.1038/srep33386 · Cited by 318 · see citing works
Plasma Fetuin-A Levels and the Risk of Myocardial Infarction and Ischemic Stroke
Weikert, C., Stefan, N., Schulze, M. B., Pischon, T., Berger, K., Joost, H., Häring, H., Boeing, H., & Fritsche, A. (2008) · Circulation · doi:10.1161/circulationaha.108.814418 · Cited by 310 · see citing works
Nonalcoholic fatty liver disease and aging: Epidemiology to management
Bertolotti, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i39.14185 · Cited by 309 · see citing works
Nutrition and physical activity in NAFLD: An overview of the epidemiological evidence
Zelber‐Sagi, S. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i29.3377 · Cited by 299 · see citing works
Self-citationInflammatory biomarkers are associated with total brain volume
Jefferson, A. L., Massaro, J. M., Wolf, P. A., Seshadri, S. S., Au, R., Vasan, R. S., Larson, M. G., Meigs, J. B., Keaney, J. F., Lipinska, I., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000257815.20548.df · Cited by 277 · see citing works
Self-citationStructural Imaging Measures of Brain Aging
Lockhart, S. N., & DeCarli, C. S. (2014) · Neuropsychology Review · doi:10.1007/s11065-014-9268-3 · Cited by 272 · see citing works
Self-citationVisceral fat is associated with lower brain volume in healthy middle‐aged adults
Debette, S., Beiser, A., Hoffmann, U., DeCarli, C. S., O’Donnell, C. J., Massaro, J. M., Au, R., Himali, J. J., Wolf, P. A., Fox, C. S., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22062 · Cited by 253 · see citing works
Self-citationNon-alcoholic fatty liver disease and risk of cardiovascular disease
Lonardo, A., Sookoian, S. C., Pirola, C. J., & Targher, G. (2015) · Metabolism · doi:10.1016/j.metabol.2015.09.017 · Cited by 236 · see citing works
Sung, K., Jeong, W. S., Wild, S. H., & Byrne, C. D. (2012) · Diabetes Care · doi:10.2337/dc11-1853 · Cited by 217 · see citing works
Sugar-sweetened beverage, diet soda, and fatty liver disease in the Framingham Heart Study cohorts
Ma, J., Fox, C. S., Jacques, P. F., Speliotes, E. K., Hoffmann, U., Smith, C. E., Saltzman, E. J., & McKeown, N. M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.032 · Cited by 212 · see citing works
Self-citationHepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study
Mellinger, J. L., Pencina, K. M., Massaro, J. M., Hoffmann, U., Seshadri, S. S., Fox, C. S., O’Donnell, C. J., & Speliotes, E. K. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.045 · Cited by 212 · see citing works
Self-citationNonalcoholic fatty liver disease is associated with cognitive function in adults
Seo, S. W., Gottesman, R. F., Clark, J. M., Hernáez, R., Chang, Y., Kim, C., Ha, K. H., Güallar, E., & Lazo, M. (2016) · Neurology · doi:10.1212/wnl.0000000000002498 · Cited by 192 · see citing works
Abdominal Obesity and Fatty Liver
Jakobsen, M. U., Berentzen, T. L., Sørensen, T. I. A., & Overvad, K. (2007) · Epidemiologic Reviews · doi:10.1093/epirev/mxm002 · Cited by 180 · see citing works
Association of Plasma Total Homocysteine Levels With Subclinical Brain Injury
Seshadri, S. S., Wolf, P. A., Beiser, A., Selhub, J., Au, R., Jacques, P. F., Yoshita, M., Rosenberg, I. H., D’Agostino, R. B., & DeCarli, C. S. (2008) · Archives of Neurology · doi:10.1001/archneur.65.5.642 · Cited by 176 · see citing works
Self-citationYamazaki, H., Tsuboya, T., Tsuji, K., Dohke, M., & Maguchi, H. (2015) · Diabetes Care · doi:10.2337/dc15-0140 · Cited by 171 · see citing works
Does the brain shrink as the waist expands?
Willette, A. A., & Kapogiannis, D. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2014.03.007 · Cited by 162 · see citing works
Fukuda, T., Hamaguchi, M., Kojima, T., Hashimoto, Y., Ohbora, A., Kato, T., Nakamura, N., & Fukui, M. (2015) · Liver International · doi:10.1111/liv.12912 · Cited by 156 · see citing works
Tan, Z. S., Beiser, A., Fox, C. S., Au, R., Himali, J. J., Debette, S., DeCarli, C. S., Vasan, R. S., Wolf, P. A., & Seshadri, S. S. (2011) · Diabetes Care · doi:10.2337/dc11-0308 · Cited by 135 · see citing works
Self-citationInterrelationship between Fatty Liver and Insulin Resistance in the Development of Type 2 Diabetes
Sung, K., & Kim, S. H. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2190 · Cited by 132 · see citing works
Should we continue to use BMI as a cardiovascular risk factor?
Franzosi, M. G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69222-2 · Cited by 124 · see citing works
Yamada, T., Fukatsu, M., Suzuki, S., Wada, T., Yoshida, T., & Joh, T. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05998.x · Cited by 113 · see citing works
Nonalcoholic Fatty Liver Disease and Vascular Function
Long, M. T., Wang, N., Larson, M. G., Mitchell, G. F., Palmisano, J. N., Vasan, R. S., Hoffmann, U., Speliotes, E. K., Vita, J. A., Benjamin, E. J., et al. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.305200 · Cited by 90 · see citing works
Self-citationZelber‐Sagi, S., Lotan, R., Shibolet, O., Webb, M., Buch, A., Nitzan, D., Halpern, Z., Santo, E., & Oren, R. (2013) · Liver International · doi:10.1111/liv.12200 · Cited by 88 · see citing works
Self-citationDoycheva, I., Watt, K. D. S., Rifai, G., Mrad, R. A., López, R., Zein, N. N., Carey, W. D., & Alkhouri, N. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4492-3 · Cited by 83 · see citing works
Abdominal obesity and lower gray matter volume: a Mendelian randomization study
Debette, S., Wolf, C., Lambert, J., Crivello, F., Soumaré, A., Zhu, Y., Schilling, S., Dufouil, C., Mazoyer, B. M., Amouyel, P., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.07.022 · Cited by 82 · see citing works
Brain Imaging and Cognitive Predictors of Stroke and Alzheimer Disease in the Framingham Heart Study
Weinstein, G., Beiser, A., DeCarli, C. S., Au, R., Wolf, P. A., & Seshadri, S. S. (2013) · Stroke · doi:10.1161/strokeaha.113.000947 · Cited by 56 · see citing works
Self-citationGhareeb, D. A., Hafez, H. S., Hussien, H. M., & Kabapy, N. F. (2011) · Metabolic Brain Disease · doi:10.1007/s11011-011-9261-y · Cited by 51 · see citing works
Harnois, D. M. (2011) · Yearbook of Gastroenterology · doi:10.1016/j.ygas.2011.07.031 · Cited by 43 · see citing works
Takahashi, A., Kono, S., Wada, A., Oshima, S., Abe, K., Imaizumi, H., Fujita, M., Hayashi, M., Okai, K., Miura, I., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174169 · Cited by 36 · see citing works
Liver disease as a risk factor for cognitive decline and dementia: An Under-recognized issue #
Yilmaz, Y. N., & Ozdogan, O. C. (2008) · Hepatology · doi:10.1002/hep.22752 · Cited by 32 · see citing works
SAPMAZ, F. P., Uzman, M., Başyığıt, S., Özkan, S., Yavuz, B., Yeniova, A. Ö., Kefeli, A., Asiltürk, Z., & Nazlıgül, Y. (2016) · Medicine · doi:10.1097/md.0000000000003280 · Cited by 31 · see citing works
Visceral Fat Is Associated with Lower Brain Volume in Healthy Middle-Aged Adults
Roizen, M. F. (2011) · Yearbook of Anesthesiology and Pain Management · doi:10.1016/j.yane.2011.01.012 · Cited by 5 · see citing works
Liver disease as a risk factor for cognitive decline and dementia: An Under-recognized issue #
Newton, J. L. (2008) · Hepatology · doi:10.1002/hep.22784 · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002 · see citing works
Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy
Rose, C. F., Amodio, P., Bajaj, J. S., Dhiman, R. K., Montagnese, S., Taylor-Robinson, S. D., Vilstrup, H., & Jalan, R. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.07.013 · Cited by 473 · see citing works
EASL Clinical Practice Guidelines on the management of hepatic encephalopathy
Montagnese, S., Rautou, P., Romero‐Gómez, M., Larsen, F. S., Shawcross, D. L., Thabut, D., Vilstrup, H., & Weißenborn, K. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.06.001 · Cited by 466 · see citing works
Obesity and aging: Molecular mechanisms and therapeutic approaches
Santos, A. L., & Sinha, S. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101268 · Cited by 240 · see citing works
Nho, K., Kueider-Paisley, A., Ahmad, S., MahmoudianDehkordi, S., Arnold, M., Risacher, S. L., Louie, G., Blach, C., Baillie, R., Han, X., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.7978 · Cited by 227 · see citing works
Gehrke, N., & Schattenberg, J. M. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.02.020 · Cited by 211 · see citing works
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165 · see citing works
Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and Depression
Labenz, C., Huber, Y., Michel, M. S., Nagel, M., Galle, P. R., Kostev, K., & Schattenberg, J. M. (2020) · Hepatology Communications · doi:10.1002/hep4.1541 · Cited by 128 · see citing works
Inflammation initiates a vicious cycle between obesity and nonalcoholic fatty liver disease
Luo, Y., & Lin, H. (2020) · Immunity Inflammation and Disease · doi:10.1002/iid3.391 · Cited by 127 · see citing works
Obesity-induced inflammation: connecting the periphery to the brain
Le Thuc, O., & García-Cáceres, C. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01079-8 · Cited by 125 · see citing works
Weinstein, G., Davis‐Plourde, K. L., Himali, J. J., Zelber‐Sagi, S., Beiser, A., & Seshadri, S. S. (2019) · Liver International · doi:10.1111/liv.14161 · Cited by 108 · see citing works
Self-citationKjærgaard, K., Mikkelsen, A. C. D., Wernberg, C. W., Grønkjær, L. L., Eriksen, P. L., Damholdt, M. F., Mookerjee, R. P., Vilstrup, H., Lauridsen, M. M., & Thomsen, K. L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040673 · Cited by 109 · see citing works
Physiological β-amyloid clearance by the liver and its therapeutic potential for Alzheimer’s disease
Cheng, Y., He, C.-Y., Tian, D.-Y., Chen, S.-H., Ren, J.-R., Sun, H.-L., Xu, M.-Y., Tan, C.-R., Fan, D.-Y., Jian, J.-M., et al. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02559-z · Cited by 105 · see citing works
Cao, L., An, Y., Zhao, Z., Liu, H., Jiang, J., Liu, W., Zhou, Y., Shi, M., Dai, W., Lv, Y., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03315-0 · Cited by 109 · see citing works
Importance of fatigue and its measurement in chronic liver disease
Gerber, L. H., Weinstein, A. A., Mehta, R., & Younossi, Z. M. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i28.3669 · Cited by 90 · see citing works
Nonalcoholic Fatty Liver Disease and Risk of Dementia: A Population-Based Cohort Study
Shang, Y., Widman, L., & Hagström, H. (2022) · Neurology · doi:10.1212/wnl.0000000000200853 · Cited by 85 · see citing works
Tuttolomondo, A., Petta, S., Casuccio, A., Maida, C. D., Corte, V. D., Daidone, M., Raimondo, D. D., Pecoraro, R., Fonte, R., Cirrincione, A., et al. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0670-7 · Cited by 80 · see citing works
Cól, J. P. D., de Lima, E. P., Pompeu, F. M., Araújo, A. C., Goulart, R. D. Á., Bechara, M. D., Laurindo, L. F., Méndez‐Sánchez, N., & Barbalho, S. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073694 · Cited by 76 · see citing works
Multi-organ imaging demonstrates the heart-brain-liver axis in UK Biobank participants
McCracken, C., Raisi‐Estabragh, Z., Veldsman, M., Raman, B., Dennis, A., Masud Husain, B., Nichols, T. E., Petersen, S. E., & Neubauer, S. (2022) · Nature Communications · doi:10.1038/s41467-022-35321-2 · Cited by 72 · see citing works
GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight
Monti, G., Moreira, D. G., Richner, M., Mutsaers, H. A. M., Ferreira, N., & Jan, A. (2022) · Cells · doi:10.3390/cells11132023 · Cited by 69 · see citing works
Weiss, N., & Thabut, D. (2019) · Liver Transplantation · doi:10.1002/lt.25420 · Cited by 72 · see citing works
Brain involvement in non-alcoholic fatty liver disease (NAFLD): A systematic review
Lombardi, R., Fargion, S. R., & Fracanzani, A. L. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.05.015 · Cited by 66 · see citing works
Sookoian, S. C., & Pirola, C. J. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15163 · Cited by 66 · see citing works
Raber, J., Arzy, S., Bertolus, J. B., Depue, B., Haas, H. E., Hofmann, S. G., Kangas, M., Kensinger, E., Lowry, C. A., Marusak, H. A., et al. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.03.015 · Cited by 62 · see citing works
Cholesterol metabolism in aging simultaneously altered in liver and nervous system
Nunes, V. S., Ferreira, G. D. S., & Quintão, E. C. R. (2022) · Aging · doi:10.18632/aging.203880 · Cited by 62 · see citing works
Hepatic Encephalopathy: From Metabolic to Neurodegenerative
Ochoa‐Sanchez, R., Tamnanloo, F., & Rose, C. F. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03372-4 · Cited by 56 · see citing works
Cheon, S. Y., & Song, J. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00836-0 · Cited by 57 · see citing works
Gentile, F., Doneddu, P. E., Riva, N., Nobile‐Orazio, E., & Quattrini, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207471 · Cited by 57 · see citing works
The liver–brain axis in metabolic dysfunction-associated steatotic liver disease
Mikkelsen, A. C. D., Kjærgaard, K., Schapira, A. H. V., Mookerjee, R. P., & Thomsen, K. L. (2024) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(24)00320-0 · Cited by 51 · see citing works
Beck, D., de Lange, A. G., Alnæs, D., Maximov, I. I., Pedersen, M. L., Leinhard, O. D., Linge, J., Simon, R. A., Richard, G., Ulrichsen, K. M., et al. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.102949 · Cited by 49 · see citing works
Weinstein, G., O’Donnell, A., Davis‐Plourde, K. L., Zelber‐Sagi, S., Ghosh, S., DeCarli, C. S., Thibault, E. G., Sperling, R. A., Johnson, K. A., Beiser, A., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215409 · Cited by 51 · see citing works
Self-citationJeong, S., Oh, Y., Choi, S., Chang, J., Kim, S. M., Son, J., Lee, G., Ahn, J. C., Lee, D. H., Koo, B., et al. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2021.0332 · Cited by 45 · see citing works
Kim, G., Oh, C. H., Kim, J., Jeong, S. J., Oh, I., Lee, J. S., Park, K., & Shim, J. (2022) · Liver International · doi:10.1111/liv.15244 · Cited by 48 · see citing works
Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany
Labenz, C., Kostev, K., Kaps, L., Galle, P. R., & Schattenberg, J. M. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06644-1 · Cited by 47 · see citing works
Lv, H., Zeng, N., Li, M., Sun, J., Wu, N., Xu, M., Chen, Q., Zhao, X., Chen, S., Liu, W., et al. (2024) · Health Data Science · doi:10.34133/hds.0087 · Cited by 46 · see citing works
Cervo, A., Shengir, M., Patel, K., & Sebastiani, G. (2020) · Current HIV/AIDS Reports · doi:10.1007/s11904-020-00531-0 · Cited by 46 · see citing works
Boccara, E., Golan, S., & Beeri, M. S. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1160426 · Cited by 45 · see citing works
Shang, Y., Nasr, P., Ekstedt, M., Widman, L., Stal, P. I., Hultcrantz, R. W., Kechagias, S., & Hagström, H. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100218 · Cited by 44 · see citing works
Yang, Y., Li, X., Liu, Z., Ruan, X., Wang, H. H., Zhang, Q., Cao, L., Song, L., Chen, Y., & Sun, Y. (2022) · Nutrients · doi:10.3390/nu14224910 · Cited by 44 · see citing works
Elevated C-reactive protein mediates the liver-brain axis: a preliminary study
Jiang, R., Wu, J., Rosenblatt, M., Dai, W., Rodriguez, R. X., Sui, J., Qi, S., Liang, Q., Xu, B., Meng, Q., et al. (2023) · eBioMedicine · doi:10.1016/j.ebiom.2023.104679 · Cited by 46 · see citing works
From Liver to Brain: How MAFLD/MASLD Impacts Cognitive Function
Medina‐Julio, D., Ramírez-Mejía, M. M., Córdova‐Gallardo, J., Peniche-Luna, E., Cantú-Brito, C. G., & Méndez‐Sánchez, N. (2024) · Medical Science Monitor · doi:10.12659/msm.943417 · Cited by 44 · see citing works
Meroni, M., Longo, M., Paolini, E., & Dongiovanni, P. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.02.007 · Cited by 44 · see citing works
Hepatic dysfunction after spinal cord injury: A vicious cycle of central and peripheral pathology?
Goodus, M. T., & McTigue, D. M. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113160 · Cited by 45 · see citing works
Liver integrity and the risk of Alzheimer's disease and related dementias
Lü, Y., Pike, J. R., Hoogeveen, R. C., Walker, K. A., Raffield, L. M., Selvin, E., Avery, C. L., Engel, S. M., Mielke, M. M., Garcia, T., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13601 · Cited by 43 · see citing works
Non-alcoholic fatty liver disease and cognitive function in middle-aged adults: the CARDIA study
Gerber, Y., VanWagner, L. B., Yaffe, K. S., Terry, J. G., Rana, J. S., Reis, J. P., & Sidney, S. S. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-01681-0 · Cited by 43 · see citing works
Intestine-liver crosstalk in Type 2 Diabetes and non-alcoholic fatty liver disease
Nawrot, M., Peschard, S., Lestavel, S., & Staels, B. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154844 · Cited by 43 · see citing works
Palmer, N. D., Kahali, B., Kuppa, A., Chen, Y., Du, X., Feitosa, M. F., Bielak, L. F., O’Connell, J. R., Musani, S. K., Guo, X., et al. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab096 · Cited by 40 · see citing works
Self-citationSayıner, M., Arshad, T., Golabi, P., Paik, J. M., Farhat, F., & Younossi, Z. M. (2020) · Hepatology International · doi:10.1007/s12072-020-10038-w · Cited by 40 · see citing works
Population-based body–brain mapping links brain morphology with anthropometrics and body composition
Gurholt, T. P., Kaufmann, T., Frei, O., Alnæs, D., Haukvik, U. K., van der Meer, D., Moberget, T., O’Connell, K. S., Leinhard, O. D., Linge, J., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01414-7 · Cited by 38 · see citing works
Impact of PNPLA3 I148M on Clinical Outcomes in Patients With MASLD
Petta, S., Armandi, A., & Bugianesi, E. (2024) · Liver International · doi:10.1111/liv.16133 · Cited by 38 · see citing works
Avenues within the gut-liver-brain axis linking chronic liver disease and symptoms
Nguyen, H. H., & Swain, M. G. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1171253 · Cited by 39 · see citing works
Kjærgaard, K., Mikkelsen, A. C. D., Landau, A. M., Eriksen, P. L., Hamilton-Dutoit, S. J., Magnusson, N. E., Thomsen, M. B., Chen, F., Vilstrup, H., Mookerjee, R. P., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100992 · Cited by 38 · see citing works
Liu, Q., Liu, C., Hu, F., Deng, X., & Zhang, Y. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.738835 · Cited by 36 · see citing works
Weinstein, G., O’Donnell, A., Frenzel, S., Xiao, T., Yaqub, A., Yilmaz, P., de Knegt, R. J., Maestre, G. E., van Lent, D. M., Long, M. T., et al. (2023) · European Journal of Neurology · doi:10.1111/ene.16048 · Cited by 35 · see citing works
Self-citationSingh, A., Kaur, N., Kaushal, S., Tyagi, R., Mathur, D., Sivapuram, M. S., Metri, K., Bammidi, S., Podder, V., Modgil, S., et al. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.07.007 · Cited by 36 · see citing works
Ahmad, N. A., Raizman, M., Weizmann, N., Wasek, B. L., Arning, E., Bottiglieri, T., Tirosh, O., & Troen, A. M. (2019) · The FASEB Journal · doi:10.1096/fj.201802683r · Cited by 33 · see citing works
The Presence and Severity of NAFLD are Associated With Cognitive Impairment and Hippocampal Damage
Miao, Y., Zhang, B., Sun, X., Ma, X., Fang, D., Zhang, W., Wu, T., Xu, X. M., Yu, C., Hou, Y., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad352 · Cited by 36 · see citing works
MAFLD progression contributes to altered thalamus metabolism and brain structure
Nucera, S., Ruga, S., Cardamone, A., Coppoletta, A. R., Guarnieri, L., Zito, M. C., Bosco, F., Macrì, R., Scarano, F., Scicchitano, M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-05228-5 · Cited by 31 · see citing works
Wang, M., Zhou, B., Zhang, Y., Ren, X.-F., Li, L., Li, B., & Ai, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.812030 · Cited by 30 · see citing works
Wang, Y., Li, Y., Liu, K., Han, X., Dong, Y., Wang, X., Wang, M., Cong, L., Zhang, Q., Tang, S. H., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15416 · Cited by 30 · see citing works
Chiara, F. D., Ferret-Miñana, A., & Ramón‐Azcón, J. (2021) · Biomedicines · doi:10.3390/biomedicines9030248 · Cited by 30 · see citing works
Giuffrè, M., Merli, N., Pugliatti, M., & Moretti, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063337 · Cited by 29 · see citing works
Bao, X., Kang, L., Yin, S., Engström, G., Wang, L., Xu, W., Xu, B., Zhang, X., & Zhang, X. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01498-5 · Cited by 27 · see citing works
Balcar, L., Krawanja, J., Scheiner, B., Paternostro, R., Simbrunner, B., Semmler, G., Jachs, M., Hartl, L., Stättermayer, A. F., Schwabl, P., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100682 · Cited by 26 · see citing works
Melazzini, L., Vitali, P., Olivieri, E., Bolchini, M., Zanardo, M., Savoldi, F., Leo, G. D., Griffanti, L., Baselli, G., Sardanelli, F., et al. (2020) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27479 · Cited by 23 · see citing works
Cerebrovascular alterations in NAFLD: Is it increasing our risk of Alzheimer's disease?
Hadjihambi, A. (2021) · Analytical Biochemistry · doi:10.1016/j.ab.2021.114387 · Cited by 24 · see citing works
Peng, Z., Duggan, M. R., Dark, H. E., Daya, G. N., An, Y., Davatzikos, C. A., Erus, G., Lewis, A., Moghekar, A., & Walker, K. A. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.08.004 · Cited by 24 · see citing works
Neurodegeneration in juvenile Iberian pigs with diet-induced nonalcoholic fatty liver disease
Zeltser, N., Meyer, I., Hernandez, G. V., Trahan, M. J., Fanter, R. K., Abo-Ismail, M. K., Glanz, H., Strand, C. R., Burrin, D. G., Frano, M. R. L., et al. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00120.2020 · Cited by 23 · see citing works
Gil‐Gómez, A., Brescia, P., Rescigno, M., & Romero‐Gómez, M. (2021) · Seminars in Liver Disease · doi:10.1055/s-0041-1723752 · Cited by 24 · see citing works
Subclinical liver traits are associated with structural and hemodynamic brain imaging markers
Yilmaz, P., Alferink, L. J. M., Cremers, L. G. M., Murad, S. D., Niessen, W. J., Ikram, M. A., & Vernooij, M. W. (2023) · Liver International · doi:10.1111/liv.15549 · Cited by 22 · see citing works
Clayton‐Chubb, D., Kemp, W. W., Majeed, A., Woods, R. L., Ryan, J. L., Murray, A. M., Chong, T. T. ‐., Lubel, J. S., Tran, C., Hodge, A. D., et al. (2024) · The Journals of Gerontology Series A · doi:10.1093/gerona/glae011 · Cited by 22 · see citing works
Nonalcoholic fatty liver disease and cognitive impairment: A prospective cohort study
Cushman, M., CALLAS, P. W., Alexander, K., Wadley, V. G., Zakai, N. A., Lidofsky, S. D., Unverzagt, F. W., & Judd, S. E. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282633 · Cited by 21 · see citing works
Golan, S., Boccara, E., Ravona‐Springer, R., Inbar, Y., Zelicha, H., Livny, A., Bendlin, B. B., Lesman‐Segev, O. H., Yore, I., Heymann, A. D., et al. (2024) · Obesity · doi:10.1002/oby.24004 · Cited by 20 · see citing works
Acharya, C., & Bajaj, J. S. (2021) · Liver Transplantation · doi:10.1002/lt.26099 · Cited by 22 · see citing works
Beller, E., Lorbeer, R., Keeser, D., Schoeppe, F., Sellner, S., Hetterich, H., Bamberg, F., Schlett, C. L., Peters, A., Ertl-Wagner, B. B., et al. (2019) · European Radiology · doi:10.1007/s00330-019-06276-8 · Cited by 20 · see citing works
Kaplan, H. S., Hooper, P. L., Gatz, M., Mack, W. J., Law, E. M., Chui, H. C., Sutherland, M. L., Sutherland, J. D., Rowan, C. J., Wann, L. S., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2205448120 · Cited by 19 · see citing works
Chen, L., Zhang, L., Liu, S., Hua, H., Zhang, L., Liu, B., & Wang, R. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.01979-23 · Cited by 19 · see citing works
Nonalcoholic Fatty Liver Disease
Ding, L., Oligschlaeger, Y., Shiri‐Sverdlov, R., & Houben, T. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_352 · Cited by 21 · see citing works
Wang, J., Yang, R., Miao, Y., Zhang, X., Paillard‐Borg, S., Fang, Z., & Xu, W. (2025) · Liver International · doi:10.1111/liv.70109 · Cited by 18 · see citing works
Emerging Links between Nonalcoholic Fatty Liver Disease and Neurodegeneration
Kelty, T. J., Dashek, R. J., Arnold, W. D., & Rector, R. S. (2023) · Seminars in Liver Disease · doi:10.1055/s-0043-1762585 · Cited by 19 · see citing works
Lü, Y., Pike, J. R., Hoogeveen, R. C., Walker, K. A., Raffield, L. M., Selvin, E., Avery, C. L., Engel, S. M., Mielke, M. M., Garcia, T., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209203 · Cited by 17 · see citing works
Arold, D., Bornstein, S. R., Perakakis, N., Ehrlich, S., & Bernardoni, F. (2024) · Metabolism: Clinical and Experimental · doi:10.1016/j.metabol.2024.155983 · Cited by 17 · see citing works
Basu, E., Mehta, M., Zhang, C., Zhao, C., Rosenblatt, R. E., Tapper, E. B., & Parikh, N. S. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.120117 · Cited by 17 · see citing works
Mikkelsen, A. C. D., Kjærgaard, K., Mookerjee, R. P., Vilstrup, H., Wegener, G., Bay-Richter, C., & Thomsen, K. L. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03551-x · Cited by 17 · see citing works
Xu, J.-L., Gu, J.-P., Wang, L., Zhu, Q., You, N., Li, J., Li, J., & Shi, J. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2201008 · Cited by 16 · see citing works
Cognitive Function in Liver Transplantation
Albhaisi, S. A. M., & Bajaj, J. S. (2020) · Current Transplantation Reports · doi:10.1007/s40472-020-00274-2 · Cited by 16 · see citing works
Cognitive impairment and liver fibrosis in non-alcoholic fatty liver disease
Parikh, N. S., Wahbeh, F., Tapia, C., Ianelli, M., Liao, V., Jaywant, A., Kamel, H., Kumar, S. R., & Iadecola, C. (2024) · BMJ Neurology Open · doi:10.1136/bmjno-2023-000543 · Cited by 15 · see citing works
Fatty liver and cerebrovascular disease: plausible association and possible mechanisms
Khanna, S., Parikh, N. S., & VanWagner, L. B. (2021) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000799 · Cited by 14 · see citing works
Deng, M., Li, Z., Sun, L., Wang, H., Tang, J., Liu, Y., Chen, X., Xu, H., & Dai, Z. (2025) · Radiology · doi:10.1148/radiol.250026 · Cited by 13 · see citing works
Chen, J., Wang, L., Zhou, Y., Zhao, S., Chen, Q., & Zheng, K. (2026) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2026.100478 · Cited by 13 · see citing works
Cerebrolysin Prevents Brain Injury in a Mouse Model of Liver Damage
Morega, S., Cătălin, B., Simionescu, C. E., Sapalidis, K. G., & Rogoveanu, I. (2021) · Brain Sciences · doi:10.3390/brainsci11121622 · Cited by 13 · see citing works
Kaya, E., & Yilmaz, Y. N. (2024) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2024.23629 · Cited by 13 · see citing works
Jeong, S., Kwon, H., Park, S., Yu, S. J., Jeong, H., Nam, K., Kwon, H., & Park, J. (2019) · European Journal of Neurology · doi:10.1111/ene.14029 · Cited by 13 · see citing works
Zhang, H., Farooqui, H. F. M., Zhu, W., Niu, T., Zhang, Z., & Zhang, H. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01211-w · Cited by 14 · see citing works
Nonalcoholic Fatty Liver Disease and Implications for Older Adults with Diabetes
Mantovani, A., Targher, G., & Zoppini, G. (2020) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2020.04.010 · Cited by 12 · see citing works
Alzheimer's disease, a metabolic disorder: Clinical advances and basic model studies (Review)
Zhou, S., Tu, L., Chen, W., Yan, G., Guo, H., Wang, X., Hu, Q., Liu, H., & Li, F. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.12351 · Cited by 12 · see citing works
Xia, W., Yang, N., & Li, Y. (2020) · Medical Science Monitor · doi:10.12659/msm.922913 · Cited by 12 · see citing works
Shu, K., Ye, X., Song, J., Huang, X., Cui, S., Zhou, Y., Liu, X., Han, L., Yan, Z., & Liu, K. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05071-6 · Cited by 11 · see citing works
Multimodal Learning-based Prediction for Nonalcoholic Fatty Liver Disease
Chen, Y., Chen, X., Han, Y., Li, H., Zhao, D., Li, J., Wang, X., & Zhou, Y. (2025) · Machine Intelligence Research · doi:10.1007/s11633-024-1506-4 · Cited by 10 · see citing works
Therapeutic effects of CD133 + Exosomes on liver function after stroke in type 2 diabetic mice
Venkat, P., Gao, H., Findeis, E. L., Chen, Z., Zacharek, A., Landschoot‐Ward, J., Powell, B., Lü, M., Liu, Z., Zhang, Z., et al. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1061485 · Cited by 10 · see citing works
- Authors
- Weinstein, G., Zelber-Sagi, S., Preis, S. R., Beiser, A. S., DeCarli, C., Speliotes, E. K., Satizabal, C. L., Vasan, R. S., & Seshadri, S.
- Affiliations
- University of Haifa (IL)
- School of Public Health, University of Haifa, Haifa, Israel
- Boston University (US)
- University of California, Davis (US)
- Broad Institute (US)
- The Framingham Study, Framingham, Massachusetts
- Corresponding author
- Weinstein, Galit
- ORCID
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2018-01-01
- Volume
- 75
- Issue
- 1
- Pages
- 97
- ISSN
- 2168-6149 (ISSN-L)
- PMC
- PMC5833484
- OpenAlex
- W2770554136
- Cited by
- 186
- References
- 59
- Citations by year
- 2026: 19 · 2025: 28 · 2024: 35 · 2023: 30 · 2022: 24 · 2021: 19 · 2020: 17 · 2019: 12 · 2018: 2
- FWCI
- 6.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (P30AG010129)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK107904, R01DK106621)
- National Institute of Neurological Disorders and Stroke (R01NS017950)
- Topics
- Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Keywords
- non-alcoholic fatty liver disease, brain volume, hippocampal hyperintensity, white matter hyperintensities, brain aging, middle-aged adults, metabolic syndrome, cognitive impairment, Framingham Offspring cohort, brain MRI, cardiovascular risk factors, insulin resistance, homocysteine
- MeSH terms
- Abdomen, Aged, Alcohol Drinking, Brain, C-Reactive Protein, Carotid Artery Diseases, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Female, Humans, Insulin Resistance, Magnetic Resonance Imaging, Male, Middle Aged, Risk Factors, Cohort Studies, Tomography Scanners, X-Ray Computed, Prevalence, Logistic Models, Metabolic Syndrome, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
